Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects on QOL When Zinc is Supplemented in Patients With Upper GI Cancer on Chemotherapy

NCT03819088 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03819088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03819088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects on QOL When Zinc is Supplemented in Patients With Upper GI Cancer on Chemotherapy
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2019
Completion date
March 22, 2022
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric carcinoma, liver and intrahepatic bile duct carcinoma, unresectable esophageal carcinoma, unresectable pancreatic carcinoma